Once you start taking cabergoline, do you have to continue taking it without stopping?

Cabergoline (Cabergoline) is an oral dopamine receptor agonist, mainly used to treat hyperprolactinemia (hyperprolactinemia galactorrhea, prolactin adenoma, etc.). It inhibits pituitary prolactin (PRL) secretion by activating dopamine D2 receptors, thereby reducing blood prolactin levels and relieving symptoms such as galactorrhea, menstrual disorders and fertility disorders. It is easy to take orally and well tolerated, and is one of the first-line drugs for hyperprolactinemia.

Cabergoline treatment usually needs to be continued for a period of time to achieve normalization of prolactin and shrinkage of adenomas. Generally, after patients start taking the drug, they need to continue taking the drug for several weeks to several months for blood prolactin monitoring and imaging review. For patients whose symptoms are significantly relieved and their blood prolactin returns to normal, they can sometimes try to gradually reduce the dosage or take medication intermittently under the guidance of a doctor. Therefore, not all patients must take it for life. The key lies in disease control and individual response.

If the patient considers stopping the drug after the blood prolactin level is stable and the adenoma size shrinks significantly, the dose must be slowly reduced or observed intermittently under the guidance of a doctor. Studies have shown that some patients may experience prolactin rebound or adenoma recurrence after stopping the drug, so blood prolactin and MRI need to be reviewed regularly. If recurrence occurs, treatment can be resumed at the original dose. The discontinuation strategy needs to be individualized and comprehensively assessed based on age, symptoms, adenoma size, and risk of recurrence.

During cabergoline treatment, patients should pay attention to regular medication, regularly monitor blood prolactin and liver function, and make dose adjustments under the guidance of a doctor. During long-term treatment, if side effects such as hypotension, dizziness, and gastrointestinal discomfort occur, you must report it to your doctor in time so that the dosage or medication time can be adjusted. Generally speaking, cabergoline does not necessarily have to be taken for life, but discontinuation of cabergoline requires caution, strict monitoring, and individualized management to ensure lasting efficacy and stable symptom control.

Reference materials:https://www.drugs.com/